Recombinant Human PCSK9 Protein (RP01148)

Product name	Recombinant Human PCSK9 Protein
Catalog No.	RP01148
Description	Recombinant Human PCSK9 Protein is produced by HEK293 cells expression system. The target protein is expressed with sequence (Gln31-Gln692) of human PCSK9 (Accession #NP_777596.2) fused with a 6×His tag at the C-terminus.
Bio-Activity	Measured by its binding ability in a functional ELISA. Immobilized Human LDLR at 5μg/mL (100 μL/well) can bind Human PCSK9 with a linear range of 0.5-294.7ng/mL.
Purity	> 92% by SDS-PAGE.
Endotoxin	< 0.1 EU/μg of the protein by LAL method.
Formulation	Lyophilized from a 0.22 μm filtered solution of PBS, pH 7.4.Contact us for customized product form or formulation.
Species	Human
Calculated MW	71.89 kDa

Synonym	FH3; HCHOLA3; LDLCQ1; NARC-1; NARC1; PC9; PCSK9; FH3; proprotein convertase subtilisin/kexin type 9; HCHOLA3; LDLCQ1; NARC-1; NARC1; PC9
Expression Host	HEK293 cells
Tag	C-His
Swiss-Prot
Gene ID

Storage	Store at -20℃.Store the lyophilized protein at -20℃ to -80 ℃ up to 1 year from the date of receipt. After reconstitution, the protein solution is stable at -20℃ for 3 months, at 2-8℃ for up to 1 week.
Reconstitution	Centrifuge the vial before opening. Reconstitute to a concentration of 0.1-0.5 mg/mL in sterile distilled water. Avoid vortex or vigorously pipetting the protein. For long term storage, it is recommended to add a carrier protein or stablizer (e.g. 0.1% BSA, 5% HSA, 10% FBS or 5% Trehalose), and aliquot the reconstituted protein solution to minimize free-thaw cycles.

* For research use only. Not for therapeutic or diagnostic purposes.